Marie Gizon, Marine C Ferrand, Vincent Fontaine, Nathalie Mougenot, Pierre-Léo Laporte, et al.. Gene Therapy with the N-terminal Fragment of Na_v1.5 for Cardiac Channelopathies: A Novel Transcomplementation Mechanism Potentiating the Cardiac Sodium Current. 2024. ⟨hal-04783067⟩

Massiré Traoré, Chiara Noviello, Amélie Vergnol, Christel Gentil, Marius Halliez, et al.. GDF5 as a rejuvenating treatment for age-related neuromuscular failure. Brain - A Journal of Neurology , 2024, 147, pp.3834 - 3848. ⟨10.1093/brain/awae107⟩. ⟨hal-04760455⟩

Justyne Feat-Vetel, Nadine Suffee, Florence Bachelot, Morgane dos Santos, Nathalie Mougenot, et al.. X-ray Radiotherapy Impacts Cardiac Dysfunction by Modulating the Sympathetic Nervous System and Calcium Transients. International Journal of Molecular Sciences, 2024, 25 (17), pp.9483. ⟨10.3390/ijms25179483⟩. ⟨hal-04698392⟩

Maria Chatzifrangkeskou, Caroline Le Dour, Wei Wu, John Morrow, Leroy Joseph, et al.. ERK1/2 directly acts on CTGF/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A/C gene. Human Molecular Genetics, 2016, 25 (11), pp.2220-2233. ⟨10.1093/hmg/ddw090⟩. ⟨hal-03862965⟩

Vanessa Ueberschlag-Pitiot, Amalia Stantzou, Julien Messéant, Megane Lemaitre, Daniel Owens, et al.. Gonad-related factors promote muscle performance gain during postnatal development in male and female mice. AJP - Endocrinology and Metabolism, 2017, 313 (1), pp.E12-E25. ⟨10.1152/ajpendo.00446.2016⟩. ⟨hal-03677800⟩

Marine Ferrand, Gauthier Giordano, Nathalie Mougenot, Pierre-Léo Laporte, Nicolas Vignier, et al.. Intracardiac electrophysiology to characterize susceptibility to ventricular arrhythmias in murine models. Frontiers in Physiology, 2024, 15, ⟨10.3389/fphys.2024.1326663⟩. ⟨hal-04446798⟩

Juliette Bignard, Fabrice Atassi, Olivier Claude, Maria-Rosa Ghigna, Nathalie Mougenot, et al.. T-cell dysregulation and inflammatory process in Gcn2 ( Eif2ak4 −/− ) deficient rats in basal and stress conditions. American Journal of Physiology - Lung Cellular and Molecular Physiology, 2023, 324 (5), pp.L609-L624. ⟨10.1152/ajplung.00460.2021⟩. ⟨hal-04247278⟩

Emma Renard, Mathieu Moreau, Pierre-Simon Bellaye, Mélanie Guillemin, Bertrand Collin, et al.. Positron Emission Tomography Imaging of Neurotensin Receptor-Positive Tumors with 68 Ga-Labeled Antagonists: The Chelate Makes the Difference Again. Journal of Medicinal Chemistry, 2021, 64 (12), pp.8564-8578. ⟨10.1021/acs.jmedchem.1c00523⟩. ⟨hal-04028618⟩

Claire Provost, Laura Rozenblum-Beddok, Valérie Nataf, Fatiha Merabtene, Aurélie Prignon, et al.. [68Ga]RGD Versus [18F]FDG PET Imaging in Monitoring Treatment Response of a Mouse Model of Human Glioblastoma Tumor with Bevacizumab and/or Temozolomide. Molecular Imaging and Biology, 2019, 21 (2), pp.297-305. ⟨10.1007/s11307-018-1224-9⟩. ⟨hal-04028702⟩

Anne Forand, Antoine Muchir, Nathalie Mougenot, Caroline Sevoz-Couche, Cécile Peccate, et al.. PPMO pre-treatment is beneficial for AAV-based gene therapy in Duchenne Muscular Dystrophy. Myologie 2019, Mar 2019, Bordeaux, France. ⟨hal-03996969⟩